| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 106.123 | 76 |
| GSM780708 | Untreated after 4 days (C2_1) | 93.2393 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 80.9894 | 72 |
| GSM780719 | Untreated after 4 days (C1_2) | 105.448 | 76 |
| GSM780720 | Untreated after 4 days (C2_2) | 101.115 | 75 |
| GSM780721 | Untreated after 4 days (C3_2) | 80.0431 | 72 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 106.918 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 80.2849 | 72 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 136.948 | 79 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 93.0055 | 74 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 93.1451 | 74 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 146.685 | 80 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 80.9894 | 72 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 102.957 | 76 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 92.8007 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 74.6462 | 70 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 100.2 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 90.4228 | 74 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 103.443 | 76 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 98.7761 | 75 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 92.697 | 74 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 81.861 | 72 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 102.105 | 76 |